| 1. |
- Andrén, Daniela, 1968
(author)
-
Long-term absenteeism due to sickness in Sweden. How long does it take and what happens after?
- 2007
-
In: European Journal of Health Economics. - : Springer. ; 8:1, s. 41-50
-
Journal article (peer-reviewed)abstract
- In this paper, we analyze exits from long-term sickness spells in Sweden. Using data for more than 2,500 people, the aim is to analyze the transition to different states: return to work, full disability pension, partial disability pension, and other exits from the labor force. Given the complexity of the exit decision, which encompasses both the individual’s choice, the medical evaluation and the decision of the insurance adjudicator, we consider the outcome as being the result of two aspects of the exit process: one that governs the duration of a spell prior to the decision to exit, and another that governs the type of exit. Therefore, the analysis is done in two steps: first, we analyze the duration of the sickness spells, and then we analyze the process that governs the type of exit. The results indicate that both individual characteristics and push factors, such as regional unemployment, are important for both components of the decision process.
|
|
| 2. |
|
|
| 3. |
- Berg, J, et al.
(author)
-
Costs and quality of life of multiple sclerosis in Sweden
- 2006
-
In: The European journal of health economics : HEPAC : health economics in prevention and care. - : Springer Science and Business Media LLC. - 1618-7598. ; 7 Suppl 2, s. S75-85
-
Journal article (peer-reviewed)
|
|
| 4. |
|
|
| 5. |
- Davidson, Thomas, et al.
(author)
-
In pursuit of QALY weights for relatives : Empirical estimates in relatives caring for older people
- 2008
-
In: European Journal of Health Economics. - : SpringerLink. - 1618-7598 .- 1618-7601. ; 9:3, s. 285-292
-
Journal article (peer-reviewed)abstract
- This study estimates quality-adjusted life-year (QALY) weights for relatives caring for an older person. The data used are from the Swedish part of the EUROFAMCARE study. A new measure is introduced called the R-QALY weight, defined as the effect on a relative’s QALY weight due to being a relative of a disabled or sick individual. R-QALY weights were created by comparing relatives’ QALY weights with population-based QALY weights. They were also created by comparing with QALY weights reassessed for a hypothetical situation in which the older person needed no care. The results indicate that R-QALY weights are small when compared with population-based weights, but large when compared with QALY weights reassessed for the hypothetical situation. Moreover, R-QALY weights were affected by relatives’ age, sex, and subjective perception of positive and negative aspects of the caregiving situation. These aspects should therefore be taken into account in health economics evaluations using a societal approach.
|
|
| 6. |
- Gerdtham, Ulf, et al.
(author)
-
Factors affecting chronic obstructive pulmonary disease (COPD)-related costs: a multivariate analysis of a Swedish COPD cohort.
- 2009
-
In: The European journal of health economics : HEPAC : health economics in prevention and care. - : Springer Science and Business Media LLC. - 1618-7598 .- 1618-7601. ; 10:2, s. 217-26
-
Journal article (peer-reviewed)abstract
- Chronic obstructive pulmonary disease (COPD) is an increasing public health problem, generating considerable costs. The objective of this study was to identify factors affecting COPD-related costs. A cohort of 179 subjects with COPD was interviewed over the telephone on four occasions about their annual use of COPD-related resources. The data set and explanatory variables were analysed by means of multivariate regression techniques for six different types of cost: societal (or total), direct (health care) and indirect (productivity), and three subcomponents of direct costs-hospitalisation, outpatient and medication. Poor lung function, dyspnoea and asthma were independently associated with higher costs. Poor lung function (severity of COPD) significantly increased all six examined cost types. Dyspnoea (breathing problems) also increased costs, though to a varying extent. The presence of reported asthma increased total, direct, outpatient and medication costs. Poor lung function and, to a lesser extent, extent of dyspnoea and concomitant asthma, were all strongly associated with higher COPD-related costs. Strong efforts should be made to prevent the progression of COPD and its symptoms.
|
|
| 7. |
- Granlund, David, 1979-, et al.
(author)
-
Fixed budgets as a cost containment measure for pharmaceuticals
- 2006
-
In: European Journal of Health Economics. - : Springer. - 1618-7598 .- 1618-7601. ; 7:1, s. 37-45
-
Journal article (other academic/artistic)abstract
- In Västerbotten County, Sweden, there are two health centers which (in contrast to all other health centers in the region) bear strict responsibility over their pharmaceutical budget. This study examined whether the prices and quantities of pharmaceuticals prescribed by physicians working at these health centers differ significantly from those prescribed by physicians at health centers with open-ended budgets. Estimation results using matching methods, which allows us to compare similar patients at the different health centers, show that the introduction of fixed pharmaceutical budgets did not affect physicians' prescription behavior, indicating that fixed budgets may not be an efficient measure to reduce costs. Another explanation is that the health centers under study already had taken measures to contain costs, making it hard to further reduce costs.
|
|
| 8. |
- Jarl, Johan, et al.
(author)
-
The Danish effect on Swedish alcohol costs An analysis based on hospitalization data from southern Sweden.
- 2006
-
In: European Journal of Health Economics. - : Springer Science and Business Media LLC. - 1618-7601 .- 1618-7598. ; 7:1, s. 46-54
-
Journal article (peer-reviewed)abstract
- This study investigated: (a) the cost and change in hospitalizations related to alcohol misuse for the healthcare sector and (b) the effect of distance to the border on alcohol-related hospitalization costs. The first objective was analyzed using descriptive statistics and the second using ordinary least squares regression on aggregated municipality data. The total cost decreased marginally during the study period while the number of patient-cases decreased substantially, presenting evidence of a substitution towards outpatient care. The increase in average treatment cost and the almost constant total cost provide evidence for a societal increase in the burden of alcohol-related diseases. We found a negative effect for distance to Denmark on alcohol-related hospitalization cost for the year 2003. The effect was smaller for 1998, suggesting that the increase in private import quotas during the study period has affected individuals’ consumption level and/or consumption pattern. We also found indications that the increase in import quotas lead to a higher cost increase for heavy consumers than for low consumers.
|
|
| 9. |
- Jarl, Johan, et al.
(author)
-
The societal cost of alcohol consumption: an estimation of the economic and human cost including health effects in Sweden, 2002
- 2008
-
In: European Journal of Health Economics. - : Springer Science and Business Media LLC. - 1618-7601 .- 1618-7598. ; 9:4, s. 351-360
-
Journal article (peer-reviewed)abstract
- This article estimates the societal cost of alcohol consumption in Sweden in 2002, as well as the effects on health and quality of life. The estimation includes direct costs, indirect costs and intangible costs. Relevant cost-of-illness methods are applied using the human capital method and prevalence-based estimates, as suggested in existing international guidelines, allowing cautious comparison with prior studies. The results show that the net cost (i.e. including protective effects of alcohol consumption) is 20.3 billion Swedish kronor (SEK) and the gross cost (counting only detrimental effects) is 29.4 billon (0.9 and 1.3% of GDP). Alcohol consumption is estimated to cause a net loss of 121,800 QALYs. The results are within the range found in prior studies, although at the low end. A large number of sensitivity analyses are performed, indicating a sensitivity range of 50%.
|
|
| 10. |
- Jönsson, Bengt, et al.
(author)
-
Patient access to rheumatoid arthritis treatments
- 2008
-
In: European Journal of Health Economics. - : Springer Science and Business Media LLC. - 1618-7601 .- 1618-7598. ; 8:Suppl. 2, s. 33-34
-
Journal article (other academic/artistic)
|
|
